Correction: Biosimilar recombinant follitropin alfa preparations versus the reference product (Gonal-F®) in couples undergoing assisted reproductive technology treatment: a systematic review and meta-analysis

被引：0
|
作者：
Christos A. Venetis
Christoph Helwig
Ben W. Mol
Su Jen Chua
Salvatore Longobardi
Raoul Orvieto
Monica Lispi
Ashleigh Storr
Thomas D’Hooghe
机构：
[1] Aristotle University of Thessaloniki,Unit for Human Reproduction, 1st Dept of OB/Gyn, Faculty of Medicine, School of Health Sciences
[2] University of New South Wales,Centre for Big Data Research in Health
[3] Kensington Campus,Department of Obstetrics and Gynecology
[4] IVF Australia,Department of Obstetrics and Gynecology
[5] Global Biostatistics,The Tarnesby
[6] Merck KGaA,Tarnowski Chair for Family Planning and Fertility Regulation
[7] University of Monash,Research Group Reproductive Medicine, Department of Development and Regeneration
[8] Alfred Health,Department of Obstetrics and Gynecology
[9] Global Clinical Development,undefined
[10] Merck Serono S.p.A (an affiliate of Merck KGaA,undefined
[11] Darmstadt 64293,undefined
[12] Germany),undefined
[13] Chaim Sheba Medical Center,undefined
[14] Tel-Hashomer,undefined
[15] Sackler Faculty of Medicine,undefined
[16] Tel-Aviv University,undefined
[17] University of Modena and Reggio Emilia,undefined
[18] GlobalMedical Affairs Fertility,undefined
[19] Research and Development,undefined
[20] Flinders Fertility,undefined
[21] College of Medicine and Public Health,undefined
[22] Flinders University,undefined
[23] Organ Systems,undefined
[24] Group Biomedical Sciences,undefined
[25] KU Leuven (University of Leuven),undefined
[26] Yale University,undefined
来源：
Reproductive Biology and Endocrinology | / 21卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
相关论文
共 35 条
  • [1] Biosimilar recombinant follitropin alfa preparations versus the reference product (Gonal-F®) in couples undergoing assisted reproductive technology treatment: a systematic review and meta-analysis
    Su Jen Chua
    Ben W. Mol
    Salvatore Longobardi
    Raoul Orvieto
    Christos A. Venetis
    Monica Lispi
    Ashleigh Storr
    Thomas D’Hooghe
    Reproductive Biology and Endocrinology, 19
  • [2] Biosimilar recombinant follitropin alfa preparations versus the reference product (Gonal-F®) in couples undergoing assisted reproductive technology treatment: a systematic review and meta-analysis
    Chua, Su Jen
    Mol, Ben W.
    Longobardi, Salvatore
    Orvieto, Raoul
    Venetis, Christos A.
    Lispi, Monica
    Storr, Ashleigh
    D'Hooghe, Thomas
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2021, 19 (01)
  • [3] Biosimilar recombinant follitropin alfa preparations versus the reference product (Gonal-F®) in couples undergoing assisted reproductive technology treatment: a systematic review and meta-analysis (vol 19, 51, 2021)
    Venetis, Christos A. A.
    Helwig, Christoph
    Mol, Ben W. W.
    Chua, Su Jen
    Longobardi, Salvatore
    Orvieto, Raoul
    Lispi, Monica
    Storr, Ashleigh
    D'Hooghe, Thomas
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2023, 21 (01)
  • [4] A systematic review and meta-analysis comparing Biosimilar versus Originator Recombinant Follitropin Alfa in women undergoing IVF/ICSI
    Longobardi, S.
    Mol, B.
    Chua, S. J.
    Wang, R.
    Venetis, C.
    Papsch, R.
    Trew, G. H.
    Orvieto, R.
    D'Hooghe, T.
    HUMAN REPRODUCTION, 2019, 34 : 106 - 106
  • [5] Correction to: The Frequency of Ovarian Hyperstimulation Syndrome and Thromboembolism with Originator Recombinant Human Follitropin Alfa (GONAL-f) for Medically Assisted Reproduction: A Systematic Review
    Erica Velthuis
    Julie Hubbard
    Salvatore Longobardi
    Thomas D’Hooghe
    Advances in Therapy, 2021, 38 : 4602 - 4602
  • [6] The Frequency of Ovarian Hyperstimulation Syndrome and Thromboembolism with Originator Recombinant Human Follitropin Alfa (GONAL-f) for Medically Assisted Reproduction: A Systematic Review
    Erica Velthuis
    Julie Hubbard
    Salvatore Longobardi
    Thomas D’Hooghe
    Advances in Therapy, 2020, 37 : 4831 - 4847
  • [7] The Frequency of Ovarian Hyperstimulation Syndrome and Thromboembolism with Originator Recombinant Human Follitropin Alfa (GONAL-f) for Medically Assisted Reproduction: A Systematic Review
    Velthuis, Erica
    Hubbard, Julie
    Longobardi, Salvatore
    D'Hooghe, Thomas
    ADVANCES IN THERAPY, 2020, 37 (12) : 4831 - 4847
  • [8] COST-EFFECTIVENESS ANALYSIS OF FOLLITROPIN ALFA PRODUCT (GONAL-F) COMPARED TO ITS BIOSIMILARS BASED ON META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Lukyanov, V
    Falla, E.
    Calvo, de Agustin E.
    Schwarze, J. E.
    D'Hooghe, T.
    Roeder, C.
    VALUE IN HEALTH, 2022, 25 (01) : S116 - S116
  • [9] LIVE BIRTH RATES AND OVARIAN HYPERSTIMULATION SYNDROME (OHSS) RISK WITH RECOMBINANT FOLLITROPIN ALFA BIOSIMILAR PREPARATIONS VERSUS ORIGINATOR PREPARATIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    Chua, Su Jen
    Longobardi, Salvatore
    Mol, Ben W.
    Wang, Rui
    Venetis, Christos
    Storr, Ashleigh
    D'Hooghe, Thomas M.
    FERTILITY AND STERILITY, 2020, 114 (03) : E164 - E165
  • [10] The Frequency of Ovarian Hyperstimulation Syndrome and Thromboembolism with Originator Recombinant Human Follitropin Alfa (GONAL-f) for Medically Assisted Reproduction: A Systematic Review (vol 37, pg 4831, 2020)
    Velthuis, Erica
    Hubbard, Julie
    Longobardi, Salvatore
    D'Hooghe, Thomas
    ADVANCES IN THERAPY, 2021, 38 (08) : 4602 - 4602
1234